TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive NCI Expects Centers To Increase Cancer Control Efforts Despite Various Obstacles They Face January 16, 1987